Single digits.As i so nicely thought we would see a few months back. That is what happens when you continue on issuing financings at successively lower prices. Wonder what price the next financing will be at, as news seemingly doesnt have the effect on share price like it used to, some things do change after all I guess. Only significant question now, is how much capital is going to be required to take this to so called clinical trials. Is it still the 3 or 4 million dollar amount that was estimated in the past. Now does that take into effect the previous dilution and dollars raised or are we talking 3 or 4 million dollars based on todays prices. Still waiting for that patent answer, didnt get quite the answer that I was looking for. 20 cents doesnt look that possible anymore, but I still hold out hope for something like it.